Detailed answers about CRUCIBLE BIOTECHNOLOGIES LIMITED, including incorporation, status, business activity, and accounts information.
When was CRUCIBLE BIOTECHNOLOGIES LIMITED founded?
CRUCIBLE BIOTECHNOLOGIES LIMITED was officially incorporated on 29 April 2026 and is registered under company number 17188031. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CRUCIBLE BIOTECHNOLOGIES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CRUCIBLE BIOTECHNOLOGIES LIMITED?
CRUCIBLE BIOTECHNOLOGIES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CRUCIBLE BIOTECHNOLOGIES LIMITED do?
CRUCIBLE BIOTECHNOLOGIES LIMITED operates in the following sectors: 20130 - Manufacture of other inorganic basic chemicals, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is CRUCIBLE BIOTECHNOLOGIES LIMITED's registered address?
The registered office address of CRUCIBLE BIOTECHNOLOGIES LIMITED is 15 Marion Crescent, Orpington, England, BR5 2DE. This is the official address filed with Companies House for legal and statutory correspondence.
Is CRUCIBLE BIOTECHNOLOGIES LIMITED financially stable?
Financial accounts for CRUCIBLE BIOTECHNOLOGIES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.